Toll Free: 1-888-928-9744

Dengue Virus - Pipeline Review, 2015

Published: Apr 23, 2015 | Pages: 51 | Publisher: GlobalData | Industry: Healthcare | Report Format: Electronic (PDF)

Dengue Virus - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, Dengue Virus - Pipeline Review, 2015" provides an overview of Dengue Virus diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dengue Virus diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dengue Virus diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dengue Virus diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 

- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dengue Virus diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6

2 Introduction 7
2.1 Dengue Virus Overview 7

3 Products under Development 8
3.1 Dengue Virus - Pipeline Products by Stage of Development 8
3.2 Dengue Virus - Pipeline Products by Territory 9
3.3 Dengue Virus - Pipeline Products by Regulatory Path 10
3.4 Dengue Virus - Pipeline Products by Estimated Approval Date 11

4 Dengue Virus - Pipeline Products under Development by Companies 12
4.1 Dengue Virus Companies - Pipeline Products by Stage of Development 12
4.2 Dengue Virus - Pipeline Products by Stage of Development 14

5 Dengue Virus Companies and Product Overview 15
5.1 Acobiom Company Overview 15
5.1.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Ceres Nanosciences, Inc. Company Overview 16
5.2.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Chembio Diagnostic Systems, Inc. Company Overview 17
5.3.1 Chembio Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Corgenix Medical Corporation Company Overview 18
5.4.1 Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Epistem Holdings Plc Company Overview 20
5.5.1 Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 FK-Biotecnologia SA Company Overview 22
5.6.1 FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 GeneFirst Ltd Company Overview 23
5.7.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 InBios International, Inc. Company Overview 24
5.8.1 InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 Innova Biotechnology Co., Ltd. Company Overview 25
5.9.1 Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 InstantLabs Medical Diagnostics Corporation Company Overview 26
5.10.1 InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 Institut Pasteur Company Overview 27
5.11.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 Malaysian Bio-Diagnostics Research Sdn Bhd Company Overview 28
5.12.1 Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 McGill University Company Overview 29
5.13.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 29
5.14 Micronics, Inc. (of Sony Group) Company Overview 30
5.14.1 Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 30
5.15 Nanyang Technological University Company Overview 31
5.15.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 31
5.16 National University of Singapore Company Overview 32
5.16.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 32
5.17 NOWDiagnostics Company Overview 33
5.17.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
5.18 QuantuMDx Group Limited Company Overview 34
5.18.1 QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.19 Quidel Corporation Company Overview 35
5.19.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.20 Roche Diagnostics International Ltd. Company Overview 37
5.20.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.21 Trinity Biotech Plc Company Overview 38
5.21.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 38
5.22 Universitas Padjadjaran Company Overview 40
5.22.1 Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview 40
5.23 University of California, Berkeley Company Overview 41
5.23.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 41
5.24 University of Texas Medical Branch at Galveston Company Overview 43
5.24.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 43
5.25 Vircell S.L Company Overview 45
5.25.1 Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 45
5.26 Whidiag SAS Company Overview 46
5.26.1 Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 46

6 Dengue Virus- Recent Developments 47

7 Appendix 48
7.1 Methodology 48
7.2 About GlobalData 50
7.3 Contact Us 51
7.4 Disclaimer 51
List of Tables

Table 1: Dengue Virus - Pipeline Products by Stage of Development 8
Table 2: Dengue Virus - Pipeline Products by Territory 9
Table 3: Dengue Virus - Pipeline Products by Regulatory Path 10
Table 4: Dengue Virus - Pipeline Products by Estimated Approval Date 11
Table 5: Dengue Virus Companies - Pipeline Products by Stage of Development 12
Table 6: Dengue Virus - Pipeline Products by Stage of Development 14
Table 7: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 15
Table 8: Diagnostic Test - Dengue - Product Status 15
Table 9: Diagnostic Test - Dengue - Product Description 15
Table 10: Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 11: Dengue Virus Test - Product Status 16
Table 12: Dengue Virus Test - Product Description 16
Table 13: Chembio Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 14: DPP Dengue Fever Assay - Product Status 17
Table 15: DPP Dengue Fever Assay - Product Description 17
Table 16: Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
Table 17: Dengue Virus Test Kit - Product Status 19
Table 18: Dengue Virus Test Kit - Product Description 19
Table 19: Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: Genedrive - Dengue Fever Assay - Product Status 21
Table 21: Genedrive - Dengue Fever Assay - Product Description 21
Table 22: FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 22
Table 23: Point Of Care Test - Dengue Fever - Product Status 22
Table 24: Point Of Care Test - Dengue Fever - Product Description 22
Table 25: GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: PCDR - Dengue Test - Product Status 23
Table 27: PCDR - Dengue Test - Product Description 23
Table 28: InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 29: DENV Detect IgA Capture ELISA - Product Status 24
Table 30: DENV Detect IgA Capture ELISA - Product Description 24
Table 31: Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 32: Rapid Test - Dengue Fever - Product Status 25
Table 33: Rapid Test - Dengue Fever - Product Description 25
Table 34: InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
Table 35: Multiple Assay Disposable Cartridge - Dengue Fever - Product Status 26
Table 36: Multiple Assay Disposable Cartridge - Dengue Fever - Product Description 26
Table 37: Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 27
Table 38: Diagnostic Assay - Dengue - Product Status 27
Table 39: Diagnostic Assay - Dengue - Product Description 27
Table 40: Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 41: Diagnostic Test - Dengue Fever - Product Status 28
Table 42: Diagnostic Test - Dengue Fever - Product Description 28
Table 43: McGill University Pipeline Products & Ongoing Clinical Trials Overview 29
Table 44: Biomarker Assay - Dengue - Product Status 29
Table 45: Biomarker Assay - Dengue - Product Description 29
Table 46: Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 30
Table 47: Wallet Test - Dengue - Product Status 30
Table 48: Wallet Test - Dengue - Product Description 30
Table 49: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 31
Table 50: Dengue Test Kit - Product Status 31
Table 51: Dengue Test Kit - Product Description 31
Table 52: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 32
Table 53: Dengue Prognostic Test Kit - Product Status 32
Table 54: Dengue Prognostic Test Kit - Product Description 32
Table 55: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
Table 56: ADEXUSDx Test - Dengue - Product Status 33
Table 57: ADEXUSDx Test - Dengue - Product Description 33
Table 58: QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview 34
Table 59: Q-POC - Dengue Fever Assay - Product Status 34
Table 60: Q-POC - Dengue Fever Assay - Product Description 34
Table 61: Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
Table 62: IsoAmp Assay - Dengue - Product Status 36
Table 63: IsoAmp Assay - Dengue - Product Description 36
Table 64: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 65: Liat Dengue Assay - Product Status 37
Table 66: Liat Dengue Assay - Product Description 37
Table 67: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 68: Diagnostic Assay - Dengue - Product Status 39
Table 69: Diagnostic Assay - Dengue - Product Description 39
Table 70: Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview 40
Table 71: Rapid Molecular Assay - Dengue - Product Status 40
Table 72: Rapid Molecular Assay - Dengue - Product Description 40
Table 73: University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 41
Table 74: Diagnostic Assay - Dengue Virus - Product Status 42
Table 75: Diagnostic Assay - Dengue Virus - Product Description 42
Table 76: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 43
Table 77: Biomarker Based Assay - Dengue Virus Infection - Product Status 44
Table 78: Biomarker Based Assay - Dengue Virus Infection - Product Description 44
Table 79: Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 45
Table 80: VIRapid Dengue DUO (Ag+Ab) Test - Product Status 45
Table 81: VIRapid Dengue DUO (Ag+Ab) Test - Product Description 45
Table 82: Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 46
Table 83: Rapid Diagnostic Test - Dengue Virus - Product Status 46
Table 84: Rapid Diagnostic Test - Dengue Virus - Product Description 46
Table 85: Glossary 49 


List of Figures

Figure 1: Dengue Virus - Pipeline Products by Stage of Development 8
Figure 2: Dengue Virus - Pipeline Products by Territory 9
Figure 3: Dengue Virus - Pipeline Products by Regulatory Path 10
Figure 4: Dengue Virus - Pipeline Products by Estimated Approval Date 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify